Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 4 (2007), Issue 5 (May)

1. Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy.
   Diabetes, 56(5): 1333-40. [Abstract] [Full-text]
2. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes.
   Diabetes, 56(5): 1210-8. [Abstract] [Full-text]
3. The emerging role of FOXO transcription factors in pancreatic beta cells.
   J Endocrinol, 193(2): 195-207. [Abstract] [Full-text]
4. Effects of a diabetes self-management program on glycemic control, coronary heart disease risk, and quality of life among Thai patients with type 2 diabetes.
   Nurs Health Sci, 9(2): 135-41. [Abstract] [Full-text]
5. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.
   Clin Genet, 71(4): 359-66. [Abstract] [Full-text]
6. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial.
   J Consult Clin Psychol, 75(2): 336-43. [Abstract] [Full-text]
7. Evidence that Rho guanine nucleotide exchange factor 11 (ARHGEF11) on 1q21 is a type 2 diabetes susceptibility gene in the Old Order Amish.
   Diabetes, 56(5): 1363-8. [Abstract] [Full-text]
8. Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats.
   Diabetes, 56(5): 1410-20. [Abstract] [Full-text]
9. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
   Diabetes, 56(5): 1324-32. [Abstract] [Full-text]
10. A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated with obesity and related metabolic abnormalities.
    Diabetes, 56(5): 1468-74. [Abstract] [Full-text]
11. Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men.
    Diabetes, 56(5): 1460-7. [Abstract] [Full-text]
12. The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity?
    Diabetes, 56(5): 1189-97. [Abstract] [Full-text]
13. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Diabetes, 56(5): 1395-402. [Abstract] [Full-text]
14. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans.
    Diabetes, 56(5): 1481-5. [Abstract] [Full-text]
15. A mutation in the TMD0-L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM).
    Diabetes, 56(5): 1357-62. [Abstract] [Full-text]
16. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice.
    Diabetes, 56(5): 1240-7. [Abstract] [Full-text]
17. Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice.
    Diabetes, 56(5): 1268-76. [Abstract] [Full-text]
18. Glycoprotein Ibalpha polymorphism T145M, elevated lipoprotein-associated phospholipase A2, and hypertriglyceridemia predict risk for recurrent coronary events in diabetic postinfarction patients.
    Diabetes, 56(5): 1429-35. [Abstract] [Full-text]
19. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.
    Diabetes, 56(5): 1475-80. [Abstract] [Full-text]
20. Variants in ARHGEF11, a candidate gene for the linkage to type 2 diabetes on chromosome 1q, are nominally associated with insulin resistance and type 2 diabetes in Pima Indians.
    Diabetes, 56(5): 1454-9. [Abstract] [Full-text]
21. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients.
    Diabetes, 56(5): 1376-81. [Abstract] [Full-text]
22. A novel approach to ultrasensitive diagnosis using supramolecular protein nanoparticles.
    FASEB J, 21(7): 1324-34. [Abstract] [Full-text]
23. Diabetes mellitus does not preclude stabilization or improvement of renal function after stent revascularization in patients with kidney insufficiency and renal artery stenosis.
    Catheter Cardiovasc Interv, 69(6): 902-7. [Abstract] [Full-text]
24. Reactions to diabetes and their relationship to time orientation.
    Int J Rehabil Res, 30(2): 127-36. [Abstract] [Full-text]
25. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Blood Coagul Fibrinolysis, 18(4): 327-34. [Abstract] [Full-text]
26. The role of vildagliptin in the management of type 2 diabetes mellitus.
    Ann Pharmacother, 41(5): 824-32. [Abstract] [Full-text]
27. Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy.
    Biochem Biophys Res Commun, 357(3): 749-54. [Abstract] [Full-text]
28. Reduced tear production in three canine endocrinopathies.
    J Small Anim Pract, 48(5): 252-6. [Abstract] [Full-text]
29. Obesity in adults: an emerging problem in urban areas of Ho Chi Minh City, Vietnam.
    Eur J Clin Nutr, 61(5): 673-81. [Abstract] [Full-text]
30. Value and significance of new diagnostic criteria of diabetes mellitus in older people.
    Arch Gerontol Geriatr, 45(1): 103-8. [Abstract] [Full-text]
31. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.
    J Clin Invest, 117(5): 1249-59. [Abstract] [Full-text]
32. Pharmacogenetics of metformin response: a step in the path toward personalized medicine.
    J Clin Invest, 117(5): 1226-9. [Abstract] [Full-text]
33. Cellular and molecular basis of wound healing in diabetes.
    J Clin Invest, 117(5): 1219-22. [Abstract] [Full-text]
34. Long-term effect of diabetes and its treatment on cognitive function.
    N Engl J Med, 356(18): 1842-52. [Abstract] [Full-text]
35. Amelioration of type II diabetes in db/db mice by continuous low-dose-rate gamma irradiation.
    Radiat Res, 167(5): 592-9. [Abstract] [Full-text]
36. Diabetes mellitus and anal sphincter pressures: an experimental model in rats.
    Dis Colon Rectum, 50(4): 517-22. [Abstract] [Full-text]
37. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.
    Am J Physiol Renal Physiol, 292(5): F1334-44. [Abstract] [Full-text]
38. Relationships and their potential for change developed in difficult type 1 diabetes.
    Qual Health Res, 17(5): 625-38. [Abstract] [Full-text]
39. Prognostic significance of myocardial ischemia during dobutamine stress echocardiography in asymptomatic patients with diabetes mellitus and no prior history of coronary events.
    Am J Cardiol, 99(9): 1193-5. [Abstract] [Full-text]
40. Urinary proteome profiling using microfluidic technology on a chip.
    J Proteome Res, 6(5): 2011-8. [Abstract] [Full-text]
41. Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners.
    J Am Med Inform Assoc, 14(3): 349-54. [Abstract] [Full-text]
42. Crossing the evidence chasm: building evidence bridges from process changes to clinical outcomes.
    J Am Med Inform Assoc, 14(3): 329-39. [Abstract] [Full-text]
43. STAMPing out Inflammation.
    Cell, 129(3): 451-2. [Abstract] [Full-text]
44. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial.
    Health Qual Life Outcomes, 5: 21. [Abstract] [Full-text]
45. Mild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mothers in the ACHOIS randomised controlled trial.
    BMC Pediatr, 7: 18. [Abstract] [Full-text]
46. Nitric oxide donors selectively reduce the expression of matrix metalloproteinases-8 and -9 by human diabetic skin fibroblasts.
    J Surg Res, 140(1): 90-8. [Abstract] [Full-text]
47. Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task.
    Behav Brain Res, 180(1): 28-41. [Abstract] [Full-text]
48. In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase.
    J Clin Endocrinol Metab, 92(5): 1961-4. [Abstract] [Full-text]
49. Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes.
    J Clin Endocrinol Metab, 92(5): 1791-5. [Abstract] [Full-text]
50. Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings.
    J Clin Endocrinol Metab, 92(5): 1773-7. [Abstract] [Full-text]
51. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.
    J Clin Endocrinol Metab, 92(5): 1881-5. [Abstract] [Full-text]
52. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis.
    J Appl Physiol, 102(5): 1969-75. [Abstract] [Full-text]
53. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.
    J Clin Endocrinol Metab, 92(5): 1886-90. [Abstract] [Full-text]
54. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial.
    J Clin Endocrinol Metab, 92(5): 1647-52. [Abstract] [Full-text]
55. Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia.
    Eur J Vasc Endovasc Surg, 33(6): 731-6. [Abstract] [Full-text]
56. Stiffness- and relaxation-based quantitation of radial left ventricular oscillations: elucidation of regional diastolic function mechanisms.
    J Appl Physiol, 102(5): 1862-70. [Abstract] [Full-text]
57. Physical activity energy expenditure may mediate the relationship between plasma leptin levels and worsening insulin resistance independently of adiposity.
    J Appl Physiol, 102(5): 1921-6. [Abstract] [Full-text]
58. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus.
    Diabetes Res Clin Pract, 77(2): 188-92. [Abstract] [Full-text]
59. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study.
    Diabetes Res Clin Pract, 77(2): 161-7. [Abstract] [Full-text]
60. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.
    Diabetes Res Clin Pract, 77(2): 231-6. [Abstract] [Full-text]
61. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders.
    Diabetes Res Clin Pract, 77(2): 245-50. [Abstract] [Full-text]
62. Hyperhomocysteinemia is associated with visceral adiposity in Japanese patients with type 2 diabetes mellitus.
    Diabetes Res Clin Pract, 77(2): 168-73. [Abstract] [Full-text]
63. High prevalence of glucose metabolism disturbance in patients with lichen planus.
    Diabetes Res Clin Pract, 77(2): 198-202. [Abstract] [Full-text]
64. Determination of the antioxidant status of plasma from type 2 diabetic patients.
    Diabetes Res Clin Pract, 77(2): 193-7. [Abstract] [Full-text]
65. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
    Diabetes Res Clin Pract, 77(2): 280-5. [Abstract] [Full-text]
66. Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
    Diabetes Res Clin Pract, 77(2): 210-4. [Abstract] [Full-text]
67. Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes.
    Diabetes Res Clin Pract, 77(2): 180-7. [Abstract] [Full-text]
68. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus.
    Diabetes Res Clin Pract, 77(2): 174-9. [Abstract] [Full-text]
69. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
    Diabetes Res Clin Pract, 77(2): 237-44. [Abstract] [Full-text]
70. High prevalence of glucose intolerance even among young adults in south India.
    Diabetes Res Clin Pract, 77(2): 269-79. [Abstract] [Full-text]
71. Metabolic improvement of male prisoners with type 2 diabetes in Fukushima Prison, Japan.
    Diabetes Res Clin Pract, 77(2): 327-32. [Abstract] [Full-text]
72. Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients.
    Diabetes Res Clin Pract, 77(2): 258-62. [Abstract] [Full-text]
73. Daily-life activities and in-shoe forefoot plantar pressure in patients with diabetes.
    Diabetes Res Clin Pract, 77(2): 203-9. [Abstract] [Full-text]
74. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study.
    Diabetes Res Clin Pract, 77(2): 300-5. [Abstract] [Full-text]
75. Hypertension in people with diabetes in sub-Saharan Africa: revealing the hidden face of the iceberg.
    Diabetes Res Clin Pract, 77(2): 293-9. [Abstract] [Full-text]
76. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
    Diabetes Res Clin Pract, 77(2): 215-22. [Abstract] [Full-text]
77. Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia.
    Diabetes Res Clin Pract, 77(2): 223-30. [Abstract] [Full-text]
78. A new approach to diabetic control: fuzzy logic and insulin pump technology.
    Med Eng Phys, 29(7): 824-7. [Abstract] [Full-text]
79. The unswallowed pill: physical activity.
    Appl Physiol Nutr Metab, 32(2): 305-6. [Abstract] [Full-text]
80. Impaired inotropic response in type 2 diabetes mellitus: a strain rate imaging study.
    Am J Hypertens, 20(5): 548-55. [Abstract] [Full-text]
81. Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients.
    Am J Hypertens, 20(5): 541-5. [Abstract] [Full-text]
82. Value of ambulatory arterial stiffness index and 24-h pulse pressure to predict progression of albuminuria in elderly people with diabetes mellitus.
    Am J Hypertens, 20(5): 493-500. [Abstract] [Full-text]
83. Influence of pulmonary status and diabetes mellitus on aortic neck dilatation following endovascular repair of abdominal aortic aneurysms: a EUROSTAR report.
    J Endovasc Ther, 14(2): 122-9. [Abstract] [Full-text]
84. "Diabetes is my companion": lifestyle and self-management among good and poor control Mexican diabetic patients.
    Soc Sci Med, 64(11): 2223-35. [Abstract] [Full-text]
85. When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?
    Diabetes Metab Res Rev, 23(4): 257-64. [Abstract] [Full-text]
86. Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study.
    Diabetes Metab Res Rev, 23(4): 286-91. [Abstract] [Full-text]
87. Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.
    Diabetes Metab Res Rev, 23(4): 292-8. [Abstract] [Full-text]
88. U-500 insulin: why, when and how to use in clinical practice.
    Diabetes Metab Res Rev, 23(4): 265-8. [Abstract] [Full-text]
89. Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.
    Diabetes Metab Res Rev, 23(4): 276-85. [Abstract] [Full-text]
90. Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: a case series.
    Int J Cardiol, 118(3): 398-9. [Abstract] [Full-text]
91. Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients.
    Diabetes Metab Res Rev, 23(4): 269-75. [Abstract] [Full-text]
92. Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study.
    Diabetes Metab Res Rev, 23(4): 311-6. [Abstract] [Full-text]
93. Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations.
    Diabetes Metab Res Rev, 23(4): 304-10. [Abstract] [Full-text]
94. Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes.
    Diabetes Metab Res Rev, 23(4): 299-303. [Abstract] [Full-text]
95. Familial aggregation and excess maternal transmission of type 2 diabetes in Tunisia.
    Postgrad Med J, 83(979): 348-51. [Abstract] [Full-text]
96. The microbiological profiles of saliva, supragingival and subgingival plaque and dental caries in adults with and without type 2 diabetes mellitus.
    Oral Microbiol Immunol, 22(3): 175-81. [Abstract] [Full-text]
97. The utility of the C-peptide in the phenotyping of patients candidates for pancreas transplantation.
    Clin Transplant, 21(3): 358-62. [Abstract] [Full-text]
98. Three-yr follow-up of a type 1 diabetes mellitus patient with an islet xenotransplant.
    Clin Transplant, 21(3): 352-7. [Abstract] [Full-text]
99. Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents.
    Cardiovasc Diabetol, 6: 14. [Abstract] [Full-text]
100. 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis.
     Biochem J, 404(2): 269-77. [Abstract] [Full-text]
101. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes.
     Am J Physiol Heart Circ Physiol, 292(5): H2073-82. [Abstract] [Full-text]
102. Acute gastric dilatation after porcine islet transplantation in a cynomolgus monkey - case history and review of the literature.
     Xenotransplantation, 14(3): 265-70. [Abstract] [Full-text]
103. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
     J Clin Epidemiol, 60(6): 554-9. [Abstract] [Full-text]
104. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
     Int J Technol Assess Health Care, 23(2): 177-83. [Abstract] [Full-text]
105. Heart transplantation in insulin-treated diabetic mellitus patients with diabetes-related complications.
     Transpl Int, 20(6): 528-33. [Abstract] [Full-text]
106. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
     Clin Exp Immunol, 148(3): 432-9. [Abstract] [Full-text]
107. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes.
     Clin Sci (Lond), 112(12): 599-606. [Abstract] [Full-text]
108. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
     Gastroenterology, 132(6): 2208-25. [Abstract] [Full-text]
109. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.
     Tissue Antigens, 69(6): 557-67. [Abstract] [Full-text]
110. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes.
     J Sex Med, 4(3): 620-30; discussion 631-32. [Abstract] [Full-text]
111. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control.
     Med Care, 45(4): 315-21. [Abstract] [Full-text]
112. Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes.
     Med Care, 45(4): 308-14. [Abstract] [Full-text]
113. Is routine electrolyte testing necessary for diabetic patients who present to the emergency department with moderate hyperglycemia?
     Eur J Emerg Med, 14(2): 82-6. [Abstract] [Full-text]
114. Anti-LFA-1 improves pig islet xenograft function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40L.
     Transplantation, 83(9): 1259-67. [Abstract] [Full-text]
115. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.
     Neurologist, 13(3): 164-7. [Abstract] [Full-text]
116. Prevalence of cardiovascular risk factors in middle-aged type 2 diabetic automobile employees assessed at the workplace--the Praeford study.
     J Occup Environ Med, 49(5): 481-3. [Abstract] [Full-text]
117. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
     Curr Opin Lipidol, 18(3): 251-7. [Abstract] [Full-text]
118. Search of type 2 diabetes susceptibility gene on chromosome 20q.
     Biochem Biophys Res Commun, 357(4): 1100-6. [Abstract] [Full-text]
119. Toxicity of diazinon and its metabolites increases in diabetic rats.
     Toxicol Lett, 170(3): 229-37. [Abstract] [Full-text]
120. Diabetes-induced changes in the renal cortical proteome assessed with two-dimensional gel electrophoresis and mass spectrometry.
     Proteomics, 7(10): 1729-42. [Abstract] [Full-text]
121. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
     Science, 316(5826): 889-94. [Abstract] [Full-text]
122. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.
     Endocr Rev, 28(3): 253-83. [Abstract] [Full-text]
123. A biodegradable copolymer for the slow release of growth hormone expedites scarring in diabetic rats.
     J Biomed Mater Res B Appl Biomater, 81(2): 291-304. [Abstract] [Full-text]
124. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals.
     Am J Hum Genet, 80(6): 1150-61. [Abstract] [Full-text]
125. Correlates of religious service attendance and contact with religious leaders among persons with co-occurring serious mental illness and type 2 diabetes.
     J Nerv Ment Dis, 195(5): 382-8. [Abstract] [Full-text]
126. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis.
     Arch Intern Med, 167(9): 956-65. [Abstract] [Full-text]
127. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients.
     Arch Intern Med, 167(9): 921-7. [Abstract] [Full-text]
128. Effects of paying physicians based on their relative performance for quality.
     J Gen Intern Med, 22(6): 872-6. [Abstract] [Full-text]
129. Care management dosage.
     J Gen Intern Med, 22(6): 736-41. [Abstract] [Full-text]
130. Results of general internal medicine consultations for diabetes mellitus in 283 cancer patients.
     Am J Med Sci, 333(5): 276-9. [Abstract] [Full-text]
131. Characteristics and in-hospital mortality of diabetics and nondiabetics with an acute coronary syndrome; the GREECS study.
     Clin Cardiol, 30(5): 239-44. [Abstract] [Full-text]
132. Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough.
     Ann N Y Acad Sci, 1103: 19-32. [Abstract] [Full-text]
133. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
     Ann N Y Acad Sci, 1103: 192-5. [Abstract] [Full-text]
134. Mouse models for studies of cardiovascular complications of type 1 diabetes.
     Ann N Y Acad Sci, 1103: 202-17. [Abstract] [Full-text]
135. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth.
     Ann N Y Acad Sci, 1103: 1-10. [Abstract] [Full-text]
136. Autoreactive T cells in a partially humanized murine model of T1D.
     Ann N Y Acad Sci, 1103: 69-76. [Abstract] [Full-text]
137. Cytotoxic T cell-mediated diabetes in RIP-CD80 transgenic mice: autoantigen peptide sensitivity and fine specificity.
     Ann N Y Acad Sci, 1103: 132-42. [Abstract] [Full-text]
138. Dosing and timing effects of anti-CD40L therapy: predictions from a mathematical model of type 1 diabetes.
     Ann N Y Acad Sci, 1103: 63-8. [Abstract] [Full-text]
139. The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes.
     Ann N Y Acad Sci, 1103: 45-62. [Abstract] [Full-text]
140. The use of idd congenic mice to identify checkpoints of peripheral tolerance to islet antigen.
     Ann N Y Acad Sci, 1103: 118-27. [Abstract] [Full-text]
141. Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene.
     Ann N Y Acad Sci, 1103: 128-31. [Abstract] [Full-text]
142. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
     Ann N Y Acad Sci, 1103: 143-51. [Abstract] [Full-text]
143. Diabetes research in jeopardy: the extinction of clinical diabetes researchers.
     Ann N Y Acad Sci, 1103: 33-44. [Abstract] [Full-text]
144. Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity.
     Ann N Y Acad Sci, 1103: 90-3. [Abstract] [Full-text]
145. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
     Ann N Y Acad Sci, 1103: 103-11. [Abstract] [Full-text]
146. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
     Ann N Y Acad Sci, 1103: 196-201. [Abstract] [Full-text]
147. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.
     Ann N Y Acad Sci, 1103: 77-89. [Abstract] [Full-text]
148. Renal p38 MAP kinase activity in experimental diabetes.
     Lab Invest, 87(6): 548-58. [Abstract] [Full-text]
149. Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats.
     Endocrinology, 148(6): 2863-9. [Abstract] [Full-text]
150. Does a carpal tunnel syndrome predict an underlying disease?
     J Neurol Neurosurg Psychiatry, 78(6): 635-7. [Abstract] [Full-text]
151. Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study.
     Cardiovasc Diabetol, 6: 13. [Abstract] [Full-text]
152. Median-radial sensory nerve comparative studies in the detection of median neuropathy at the wrist in diabetic patients.
     Clin Neurophysiol, 118(6): 1405-9. [Abstract] [Full-text]
153. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.
     Br J Ophthalmol, 91(6): 822-6. [Abstract] [Full-text]
154. Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study.
     Br J Ophthalmol, 91(6): 761-5. [Abstract] [Full-text]
155. Detection of free elastin-derived peptides among diabetic children.
     Atherosclerosis, 192(2): 342-7. [Abstract] [Full-text]
156. Significant hypoglycemia secondary to icodextrin peritoneal dialysate in a diabetic patient.
     Anesth Analg, 104(6): 1473-4, table of contents. [Abstract] [Full-text]
157. Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus.
     Metabolism, 56(6): 838-46. [Abstract] [Full-text]
158. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women's Health in the Lund Area study.
     Metabolism, 56(6): 825-9. [Abstract] [Full-text]
159. The effects of a glucose load and sympathetic challenge on autonomic function in obese women with and without type 2 diabetes mellitus.
     Metabolism, 56(6): 778-85. [Abstract] [Full-text]
160. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus.
     Metabolism, 56(6): 745-50. [Abstract] [Full-text]
161. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise.
     Metabolism, 56(6): 732-44. [Abstract] [Full-text]
162. Relationship of flow rate, uric acid, peroxidase, and superoxide dismutase activity levels with complications in diabetic patients: can saliva be used to diagnose diabetes?
     Antioxid Redox Signal, 9(6): 765-73. [Abstract] [Full-text]
163. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats.
     Reprod Toxicol, 23(4): 486-98. [Abstract] [Full-text]
164. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.
     J Biol Chem, 282(21): 15717-29. [Abstract] [Full-text]
165. Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences.
     Reprod Toxicol, 23(4): 578-87. [Abstract] [Full-text]
166. Intraepidermal nerve fiber density as a marker of early diabetic neuropathy.
     Muscle Nerve, 35(5): 591-8. [Abstract] [Full-text]
167. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility.
     Occup Environ Med, 64(6): 373-9. [Abstract] [Full-text]
168. Reversal of Sjogren's-like syndrome in non-obese diabetic mice.
     Ann Rheum Dis, 66(6): 812-4. [Abstract] [Full-text]
169. Diabetes insipidus as a complication after pituitary surgery.
     Nat Clin Pract Endocrinol Metab, 3(6): 489-94. [Abstract] [Full-text]
170. Altered proximal aortic stiffness and endothelin plasma levels in diabetic patients with end-stage renal disease.
     ASAIO J, 53(3): 343-50. [Abstract] [Full-text]
171. Serum glucose changes during insulin therapy in pediatric patients with diabetic ketoacidosis.
     Am J Ther, 14(3): 265-8. [Abstract] [Full-text]
172. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study.
     Biochemistry, 46(21): 6417-28. [Abstract] [Full-text]
173. A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey.
     Clin Chem, 53(6): 1092-8. [Abstract] [Full-text]
174. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
     Exp Neurol, 205(2): 425-36. [Abstract] [Full-text]
175. Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes.
     BMC Med Res Methodol, 7: 18. [Abstract] [Full-text]
176. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes.
     Psychosom Med, 69(4): 300-5. [Abstract] [Full-text]
177. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients.
     Clin Oral Investig, 11(2): 115-20. [Abstract] [Full-text]
178. A nurse short message service by cellular phone in type-2 diabetic patients for six months.
     J Clin Nurs, 16(6): 1082-7. [Abstract] [Full-text]
179. The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial.
     BMC Public Health, 7: 74. [Abstract] [Full-text]
180. Improving organisational systems for diabetes care in Australian Indigenous communities.
     BMC Health Serv Res, 7: 67. [Abstract] [Full-text]
181. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
     Eur J Hum Genet, 15(6): 679-84. [Abstract] [Full-text]
182. Coronary artery disease screening in diabetic patients: how good is guideline adherence?
     Swiss Med Wkly, 137(13): 199-204. [Abstract] [Full-text]
183. Recipes for creating animal models of diabetic cardiovascular disease.
     Circ Res, 100(10): 1415-27. [Abstract] [Full-text]
184. Retinal vascular caliber, diabetes, and retinopathy.
     Am J Ophthalmol, 143(6): 1024-6. [Abstract] [Full-text]
185. Recurrent gestational diabetes: risk factors, diagnosis, management, and implications.
     Semin Perinatol, 31(3): 176-84. [Abstract] [Full-text]
186. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents.
     Lancet, 369(9575): 1823-31. [Abstract] [Full-text]
187. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication.
     Am J Gastroenterol, 102(6): 1237-43. [Abstract] [Full-text]
188. Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting.
     Diabetes Care, 30(6): 1638-46. [Abstract] [Full-text]
189. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
     J Pept Sci, 13(6): 400-5. [Abstract] [Full-text]
190. Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset.
     J Virol, 81(12): 6446-58. [Abstract] [Full-text]
191. Quantitative trait loci for fasting glucose in young Europeans replicate previous findings for type 2 diabetes in 2q23-24 and other locations.
     Diabetes, 56(6): 1742-5. [Abstract] [Full-text]
192. Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: a tagging-single nucleotide polymorphism haplotype analysis.
     Diabetes, 56(6): 1586-91. [Abstract] [Full-text]
193. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
     Diabetes, 56(6): 1737-41. [Abstract] [Full-text]
194. A novel susceptibility locus on rat chromosome 8 affects spontaneous but not experimentally induced type 1 diabetes.
     Diabetes, 56(6): 1731-6. [Abstract] [Full-text]
195. What is the best predictor of future type 2 diabetes?
     Diabetes Care, 30(6): 1544-8. [Abstract] [Full-text]
196. Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.
     Diabetes Care, 30(6): 1364-9. [Abstract] [Full-text]
197. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes.
     Diabetes Care, 30(6): 1513-9. [Abstract] [Full-text]
198. Perioperative management of the diabetic patient.
     Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103(6): 731-7. [Abstract] [Full-text]
199. Strong association between time watching television and blood glucose control in children and adolescents with type 1 diabetes.
     Diabetes Care, 30(6): 1567-70. [Abstract] [Full-text]
200. Severe hypoglycemia and smoking in a long-term type 1 diabetic population: Wisconsin Epidemiologic Study of Diabetic Retinopathy.
     Diabetes Care, 30(6): 1437-41. [Abstract] [Full-text]
201. Effect of BMI on lifetime risk for diabetes in the U.S.
     Diabetes Care, 30(6): 1562-6. [Abstract] [Full-text]
202. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
     Diabetes Care, 30(6): 1357-63. [Abstract] [Full-text]
203. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells.
     Diabetes, 56(6): 1534-43. [Abstract] [Full-text]
204. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
     Diabetes, 56(6): 1671-9. [Abstract] [Full-text]
205. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
     Diabetes, 56(6): 1718-26. [Abstract] [Full-text]
206. Prediction of severe hypoglycemia.
     Diabetes Care, 30(6): 1370-3. [Abstract] [Full-text]
207. A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
     Diabetes Care, 30(6): 1480-6. [Abstract] [Full-text]
208. A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality.
     Diabetes Care, 30(6): 1473-9. [Abstract] [Full-text]
209. Racial and ethnic variation in access to health care, provision of health care services, and ratings of health among women with histories of gestational diabetes mellitus.
     Diabetes Care, 30(6): 1459-65. [Abstract] [Full-text]
210. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study.
     Diabetes Care, 30(6): 1507-12. [Abstract] [Full-text]
211. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
     Diabetes Care, 30(6): 1374-83. [Abstract] [Full-text]
212. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).
     Diabetes, 56(6): 1577-85. [Abstract] [Full-text]
213. Body size and shape changes and the risk of diabetes in the diabetes prevention program.
     Diabetes, 56(6): 1680-5. [Abstract] [Full-text]
214. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
     Diabetes, 56(6): 1662-70. [Abstract] [Full-text]
215. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.
     Diabetes, 56(6): 1686-93. [Abstract] [Full-text]
216. Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes.
     Diabetes, 56(6): 1727-30. [Abstract] [Full-text]
217. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.
     Diabetes Care, 30(6): 1487-93. [Abstract] [Full-text]
218. The underuse of screening services among elderly women with diabetes.
     Diabetes Care, 30(6): 1466-72. [Abstract] [Full-text]
219. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes.
     Diabetes Care, 30(6): 1390-5. [Abstract] [Full-text]
220. Exercise capacity and body mass as predictors of mortality among male veterans with type 2 diabetes.
     Diabetes Care, 30(6): 1539-43. [Abstract] [Full-text]
221. Diabetes care in extended-care facilities: appropriate intensity of care?
     Diabetes Care, 30(6): 1454-8. [Abstract] [Full-text]
222. Safe at school: a Virginia experience.
     Diabetes Care, 30(6): 1396-8. [Abstract] [Full-text]
223. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes.
     Diabetes, 56(6): 1592-9. [Abstract] [Full-text]
224. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists.
     Diabetes Care, 30(6): 1448-53. [Abstract] [Full-text]
225. Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes.
     Diabetes Care, 30(6): 1399-405. [Abstract] [Full-text]
226. Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.
     Diabetes Care, 30(6): 1351-6. [Abstract] [Full-text]
227. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study.
     Diabetes Care, 30(6): 1430-6. [Abstract] [Full-text]
228. Relationship of physician volume with process measures and outcomes in diabetes.
     Diabetes Care, 30(6): 1442-7. [Abstract] [Full-text]
229. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
     Diabetes, 56(6): 1527-33. [Abstract] [Full-text]
230. Pathogenesis of spinally mediated hyperalgesia in diabetes.
     Diabetes, 56(6): 1569-76. [Abstract] [Full-text]
231. Genetic and phenotypic diversity of echovirus 30 strains and pathogenesis of type 1 diabetes.
     J Med Virol, 79(7): 945-55. [Abstract] [Full-text]
232. Cyclohexenonic long-chain fatty alcohol has therapeutic effects on diabetes-induced angiopathy in the rat aorta.
     Eur J Pharmacol, 567(1): 139-44. [Abstract] [Full-text]
233. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.
     Atherosclerosis, 193(1): 55-61. [Abstract] [Full-text]
234. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.
     Arch Intern Med, 167(10): 1076-82. [Abstract] [Full-text]
235. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.
     Arch Intern Med, 167(10): 1068-74. [Abstract] [Full-text]
236. Patients with diabetes mellitus undergoing cardiac surgery are at greater risk for developing intraoperative myocardial acidosis.
     J Thorac Cardiovasc Surg, 133(6): 1566-72. [Abstract] [Full-text]
237. CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes.
     Biochem Biophys Res Commun, 358(3): 831-6. [Abstract] [Full-text]
238. Cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer.
     Br J Cancer, 96(11): 1747-9. [Abstract] [Full-text]
239. Ca2+-secretion coupling is impaired in diabetic Goto Kakizaki rats.
     J Gen Physiol, 129(6): 493-508. [Abstract] [Full-text]
240. Prevalence of nondiabetic renal disease in diabetic patients.
     Am J Nephrol, 27(3): 322-8. [Abstract] [Full-text]
241. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study.
     Stroke, 38(6): 1739-43. [Abstract] [Full-text]
242. TXNIP regulates peripheral glucose metabolism in humans.
     PLoS Med, 4(5): e158. [Abstract] [Full-text]
243. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
     PLoS Med, 4(5): e154. [Abstract] [Full-text]
244. Doxycycline: a pilot study to reduce diabetic proteinuria.
     Am J Nephrol, 27(3): 269-73. [Abstract] [Full-text]
245. Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha.
     BJU Int, 99(6): 1488-94. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.